In a Phase 3 clinical trial. MG-ADL scores improved significantly more in those given nipocalimab than in those treated with a placebo.#myastheniagravis #MGWarrior #MyastheniaGravisAwareness #MGStrong
#myastheniagravis #MGWarrior #MyastheniaGravisAwareness #MGStrong